510(k) Report

510(k) · Cleared

Cleared

Truecare Biomedix Intravascular Administration Set, Truecare Biomedix Extension Set

K111351510(k) AbbreviatedCleared Sep 29, 2011139-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Us Infusion Dba Truecare Biomedix · FPA Set, Administration, Intravascular

Cleared on Sep 29, 2011 as substantially equivalent to K050906 (Vitalcare Group, Inc., 2005) after a 139-day review. Its family tree reaches back 2 generations to 1993. 7 later devices descend from it.

Decided
Sep 29, 2011
Review
139 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K925465 (1993). 7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2012: 2 descendants cleared2023: 2 descendants cleared2015: 1 descendant cleared2021: 1 descendant cleared2017: 1 descendant clearedK925465 · Teleradiology Device & Component of Pacs Component · Life Care Imaging · 1993K050906 · Vitalcare I.V. Administration Set · Vitalcare Group, Inc. · 20051990200020102020
Descendants, by generation 1 generation forward: 3 descendants2 generations forward: 4 descendants K050906 · Vitalcare I.V. Administration Set · Vitalcare Group, Inc. · 2005K925465 · Teleradiology Device & Component of Pacs Component · Life Care Imaging · 19930
  1. Root · 2 generations backK925465 Teleradiology Device & Component of Pacs ComponentLife Care Imaging · 1993
  2. 1 generation backK050906 Vitalcare I.V. Administration SetVitalcare Group, Inc. · 2005
  3. This deviceK111351 Truecare Biomedix Intravascular Administration Set, Truecare…Us Infusion Dba Truecare Biomedix · 2011
  4. Descendant · cites it directly · 4 of its ownK121803 Intravascular Administration SetActa Medical, LLC · 2012
  5. Descendant · 2 generations on · 0 of its ownK230992 DJF Intravascular Administration SetYangzhou Wei DE LI Trade Co., Ltd. · 2023
  6. Descendant · cites it directly · 0 of its ownK223645 I.V. Administration Set, I.V. Extension SetBq Plus Medical Co., Ltd. · 2023
  7. Descendant · 2 generations on · 0 of its ownK210381 I.V. Administration SetBq Plus Medical Co., Ltd. · 2021
  8. Descendant · 2 generations on · 0 of its ownK162601 Infusion Set for Single UseShinva Ande Healthcare Apparatus Co., Ltd. · 2017

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2012: 22015: 12017: 12021: 12023: 2
2012high 2 (2012) · low 0 (2013)2026

Most influential descendants

Showing 5 of 7 · See all
  • K121803Intravascular Administration SetActa Medical, LLC · 2012 · cites it directly4descendants
  • K230992DJF Intravascular Administration SetYangzhou Wei DE LI Trade Co., Ltd. · 2023 · 2 generations on0descendants
  • K223645I.V. Administration Set, I.V. Extension SetBq Plus Medical Co., Ltd. · 2023 · cites it directly0descendants
  • K210381I.V. Administration SetBq Plus Medical Co., Ltd. · 2021 · 2 generations on0descendants
  • K162601Infusion Set for Single UseShinva Ande Healthcare Apparatus Co., Ltd. · 2017 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K925465Teleradiology Device & Component of Pacs ComponentLife Care Imaging1993—
−1K050906Vitalcare I.V. Administration SetVitalcare Group, Inc.2005—
0 (this device)K111351Truecare Biomedix Intravascular Administration Set, Truecare Biomedix…Us Infusion Dba Truecare Biomedix2011—
+1K121803Intravascular Administration SetActa Medical, LLC2012—
+2K230992DJF Intravascular Administration SetYangzhou Wei DE LI Trade Co., Ltd.2023—
+1K223645I.V. Administration Set, I.V. Extension SetBq Plus Medical Co., Ltd.2023—
+2K210381I.V. Administration SetBq Plus Medical Co., Ltd.2021—
+2K162601Infusion Set for Single UseShinva Ande Healthcare Apparatus Co., Ltd.2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201220
201510
201710
202110
202320
FIG. 1 — Lineage of K111351, 1993–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K050906Vitalcare I.V. Administration Set
Summary page 2
…590-5537 Email: Acompton(qi.tcbiornedix.coni Common Name of Device: Intravascular Administration Set Predicate Device: Vitalcare 3 In I Tubing (K050906) Panel: General Hospital and Personal Use Product Code: FPA Device Classification: 11…
Vitalcare Group, Inc.2005—

Also cleared against K050906: 2 other devices →

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K121803Intravascular Administration SetActa Medical, LLC20124
K223645I.V. Administration Set, I.V. Extension SetBq Plus Medical Co., Ltd.20230
K112863Enteral Administration Set with Solution Container, Enteral Administration Set, Enteral…Acta Medical, LLC20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 12.6 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K121803 (Acta Medical, LLC, 2012) has gone furthest, with 4 descendants of its own.
  • 2 other devices also cite its predicate K050906.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

Truecare Biomedix Intravascular administration set intended use is to deliver sterile, infusion fluid from a container to the patient with or without flow control features. Truecare Biomedix infusion tubing may act as an extension of other infusion tubing in delivering intravenous fluids from a container to patient.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K111351: Truecare Biomedix Intravascular Administration Set, Truecare Biomedix Extension Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111351

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026